HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantification of pelvic organ prolapse in mice: vaginal protease activity precedes increased MOPQ scores in fibulin 5 knockout mice.

Abstract
Two mouse models of pelvic organ prolapse have been generated recently, both of which have null mutations in genes involved in elastic fiber synthesis and assembly (fibulin 5 and lysyl oxidase-like 1). Interestingly, although these mice exhibit elastinopathies early in life, pelvic organ prolapse does not develop until later in life. In this investigation we developed and validated a tool to quantify the severity of pelvic organ prolapse in mice, and we used this tool prospectively to study the role of fibulin 5, aging, and vaginal proteases in the development of pelvic organ prolapse. The results indicate that >90% of Fbln5(-/-) mice develop prolapse by 6 mo of age, even in the absence of vaginal delivery, and that increased vaginal protease activity precedes the development of prolapse.
AuthorsCecilia K Wieslander, David D Rahn, Donald D McIntire, Jesús F Acevedo, Peter G Drewes, Hiromi Yanagisawa, R Ann Word
JournalBiology of reproduction (Biol Reprod) Vol. 80 Issue 3 Pg. 407-14 (Mar 2009) ISSN: 0006-3363 [Print] United States
PMID18987327 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Validation Study)
Chemical References
  • Extracellular Matrix Proteins
  • Fbln5 protein, mouse
  • Recombinant Proteins
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Aging (metabolism)
  • Animals
  • Elastic Tissue (metabolism)
  • Extracellular Matrix Proteins (genetics, metabolism)
  • Female
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mice
  • Mice, Knockout
  • Models, Animal
  • Observer Variation
  • Recombinant Proteins (genetics, metabolism)
  • Severity of Illness Index
  • Uterine Prolapse (metabolism, physiopathology)
  • Vagina (metabolism, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: